By confirming the below negative trends, they are trying to soften the market before the bombshell(s) are dropped upon results day...
Metric: HY22 / HY21 / HY20
Revenue as a % of TTV: 6.7% / 6.9% / 7.2% - down (bad!) 3 half years running
Cash Gross Profit as a % of TTV: 2.1% / 3.7% / 3.7% - down (bad!) 3 half years running
Net bad debts: 2.6% / 1.93% / 1.68% - up (bad!) 3 half years running although this metric is a bit hard to compare as they only like to disclose AU numbers previously not group numbers
Cash EBITDA: -$108.1m / $0.2m / $1.5m - down (bad!) 3 half years running
Cash EBITDA is probably the most important metric, yet it isn't mentioned until towards the end of the announcement and while this isn't profit (ie NPAT) it is the trend that is most important - and this is going backwards BIG TIME!
Also of note, the bit around undertaking a series of cost saving initiatives (also towards the end of the announcement) - they haven't mentioned these words before and clearly worried growth is slowing massively and/or they're about to run out of cash and can't economically raise much given the share price is down almost 80% on last year
What a disaster
- Forums
- ASX - By Stock
- ZIP
- Ann: HY22 Results Update
Ann: HY22 Results Update, page-15
-
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZIP (ASX) to my watchlist
|
|||||
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.774B |
Open | High | Low | Value | Volume |
$1.60 | $1.62 | $1.57 | $7.305M | 4.567M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 53489 | $1.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.61 | 71554 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 53865 | 1.600 |
12 | 99158 | 1.595 |
22 | 246625 | 1.590 |
13 | 162624 | 1.585 |
13 | 77772 | 1.580 |
Price($) | Vol. | No. |
---|---|---|
1.605 | 71511 | 17 |
1.610 | 145621 | 20 |
1.615 | 196251 | 17 |
1.620 | 227621 | 20 |
1.625 | 164262 | 14 |
Last trade - 10.33am 16/07/2024 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online